STOCK TITAN
  1. Home
  2. News
  3. LH

Labcorp Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary
Labcorp (LH) declares a cash dividend of $0.72 per share of common stock, payable on June 12, 2024, to stockholders of record as of May 28, 2024.
Positive
  • None.
Negative
  • None.

BURLINGTON, N.C., April 11, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 12, 2024, to stockholders of record as of the close of business on May 28, 2024.

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-declares-quarterly-dividend-302114304.html

SOURCE Laboratory Corporation of America Holdings

Labcorp has declared a cash dividend of $0.72 per share of common stock.

The dividend will be payable on June 12, 2024.

Stockholders of record as of the close of business on May 28, 2024, are eligible to receive the Labcorp dividend.
Stock LH logo
Laboratory Corp. Of America Holdings

NYSE:LH

LH Rankings

#584 Ranked by Market Cap
#1736 Ranked by Stock Gains
#1633 Ranked by Dividends

LH Latest News

Apr 29, 2024
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Apr 25, 2024
Labcorp Announces 2024 First Quarter Results
Apr 24, 2024
Labcorp Announces Winning Bid for Select Assets of Invitae
Apr 24, 2024
Invitae Enters into Agreement with Labcorp for Sale of Business
Apr 15, 2024
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw

LH Stock Data

Diagnostic Imaging Centers
Health Care and Social Assistance
Link
Health Services, Services to the Health Industry, Manufacturing, Dental Laboratories
US
Burlington

About LH

recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.